LAMICTAL 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES

Glaxosmithkline Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 88b314a57f4d94bc
Drug Cima Aemps Name: LAMICTAL 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number: 33122.02.00
Holder Company Name: Glaxosmithkline Gmbh & Co. Kg
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/glaxosmithkline-gmbh-and-co-kg
Authorization Date: 2022-01-20
Dosage Form: COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: Yes
Company Name: Glaxosmithkline Gmbh & Co. Kg
Company Detail Path: /organization/glaxosmithkline-gmbh-and-co-kg

LAMOTRIGINA

50 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 20, 2022

Approval ID

88b314a57f4d94bc

Type

Standard